Navigation Links
'Superpowered' Bacteria May Lurk Behind Sinus Infections
Date:9/12/2012

in mind.

Dr. Jordan Josephson, a sinus and allergy specialist at Lenox Hill Hospital in New York City, cautioned that the picture is even more complicated because of the presence of other things in the sinuses, such as fungus.

Another sinus specialist, Dr. Reginald Baugh, chair of otolaryngology at the University of Toledo in Ohio, agreed that other factors are part of sinus infections. "Additional studies are indicated to replicate and further substantiate their findings," he said.

Baugh added that the findings of the study sound reasonable. It's possible, he said, that doctors have done the wrong thing by targeting germs for death instead of focusing on harmony among bacteria in the sinuses.

It may make more sense to emphasize "harmony within the bacterial community rather than the scorched-earth policy of antibiotic therapy," he said. "Whether or not it is effective remains to be proven."

The study appears in the Sept. 12 issue of the journal Science Translational Medicine.

More information

For more about sinus infections, try the U.S. National Library of Medicine.

SOURCE: Susan Lynch, Ph.D., associate professor, medicine, University of California, San Francisco; Jordan S. Josephson, M.D., sinus and allergy specialist, Lenox Hill Hospital, New York City, and author of "Sinus Relief Now;" Reginald Baugh, M.D., professor and chair, otolaryngology, University of Toledo, Ohio; Sept. 12, 2012, Science Translational Medicine


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Feces-Linked Bacteria Found at Lake Erie Beaches
2. Could Bacteria in Skin Mites Help Cause Rosacea?
3. New antibacterial coating for sutures could reduce infections after surgery
4. Trudeau researchers identify unforeseen regulation of the anti-bacterial immune response
5. Microbiology and Genome Experts Quell Deadly Bacteria Outbreak
6. NIH uses genome sequencing to help quell bacterial outbreak in Clinical Center
7. Genes carried by E. coli bacteria linked to colon cancer
8. Protective bacteria in the infant gut have resourceful way of helping babies break down breast milk
9. Chronic exposure to staph bacteria may be risk factor for lupus, Mayo study finds
10. Leveraging bacteria in drinking water to benefit consumers
11. AuCoin gets $600,000 to refine new test for deadly bacterial infection melioidosis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Superpowered' Bacteria May Lurk Behind Sinus Infections
(Date:7/1/2015)... ... July 01, 2015 , ... METTLER TOLEDO is pleased to ... pans, ML-T balances give operators the room they need to carry out weighing ... makes ML-T balances a perfect choice for day-to-day weighing in nearly any analytical ...
(Date:7/1/2015)... ... July 01, 2015 , ... Northbound Treatment Services announced today ... Relations. , Emily originally entered the behavioral healthcare industry as an academic ... academic curriculum for clients to engage in their educational journey while in treatment. ...
(Date:7/1/2015)... City, UT (PRWEB) , ... July 01, 2015 ... ... compare the different philosophies and approaches to case management, placement, sober companionship and ... different training and approaches to working with and transporting clients with anxiety, ADHD, ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... southwest Georgia and the Florida Panhandle, the regional southeast Alabama community health ... messaging and clinical communications workflow solution provider. TelmedIQ, a burgeoning leader in ...
(Date:7/1/2015)... ... July 01, 2015 , ... Nutritional Products International, a brand focused ... products, recently attended the 2015 ECRM Diet, Vitamin & Sports Nutrition conference in Tampa, ... The ECRM trade show allows companies the chance to meet with a ...
Breaking Medicine News(10 mins):Health News:METTLER TOLEDO Launches Compact ML-T Balances: Larger Pan Offers Greater Weighing Flexibility in Tight Spaces 2Health News:Northbound Treatment Services Welcomes Emily Orrick as Director of Referral Relations 2Health News:All Kinds of Therapy – Announces New Partnership Feature, Therapeutic Experts 2Health News:Southeast Alabama Community Health System Chooses TelmedIQ to Meet Secure Text Messaging Challenges for Healthcare 2Health News:NPI Meets With Top Retail Figures at ECRM Conference 2
... under a ,Pay or Play, law, 10,entry-level employees will ... new study presented as,part of a Cornell University symposium ... provide health insurance to their employees or a pay,fine, ... the work,force., The study sponsored by the Employment ...
... success in helping children , FRIDAY, Nov. 9 (HealthDay ... juvenile rheumatoid arthritis, according to studies presented this week ... Boston. , One study found that abatacept, used to ... be a well-tolerated treatment for children and adolescents with ...
... 24 and Taclonex; Company ... financial guidance, ST. DAVID,S, Bermuda, Nov. 9 Warner Chilcott,Limited ... ended,September 30, 2007. Revenue in the quarter ended September 30, 2007 ... The,primary drivers of the increase in revenue were the net sales ...
... Del., Nov. 9 AstraZeneca (NYSE:,AZN) announced today ... has,approved CRESTOR(R) (rosuvastatin calcium) as an adjunct to ... with elevated cholesterol.,This new indication gives CRESTOR an ... "This new indication allows us to share what ...
... RURAL HALL, N.C., EXTON, Pa. and SAN DIEGO, ... a southeastern US,provider of oncology equipment sales and ... strategic alliance with Radiology Oncology Systems, Inc.,(ROS), an ... and Acceletronics, Inc., a US provider of oncology ...
... 8 State,Compensation Insurance Fund is presenting a ... Fund,s Employer Education Series, featuring its own,innovative and ... seminar entitled "Watch Your Back",introduces an educational and ... the very people they are trying to protect ...
Cached Medicine News:Health News:New Study: Health Insurance Mandates on Employers Hurt Low-Income Employees 2Health News:Drugs Can Ease Juvenile Rheumatoid Arthritis 2Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 2Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 3Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 4Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 5Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 6Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 7Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 8Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 9Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 10Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 11Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 12Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 13Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 14Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 15Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 16Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 17Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 18Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 19Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 20Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 21Health News:CRESTOR(R) Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated Cholesterol 2Health News:CRESTOR(R) Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated Cholesterol 3Health News:CRESTOR(R) Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated Cholesterol 4Health News:RS&A, Inc. Announces It Has Joined Radiology Oncology Systems, Inc. (ROS) and Acceletronics, Inc. in a Strategic Alliance to Better Serve Its Customers in the Southeastern US 2Health News:RS&A, Inc. Announces It Has Joined Radiology Oncology Systems, Inc. (ROS) and Acceletronics, Inc. in a Strategic Alliance to Better Serve Its Customers in the Southeastern US 3Health News:Free Seminar Features State Fund's Back Connection(TM), November 14, in Chico 2Health News:Free Seminar Features State Fund's Back Connection(TM), November 14, in Chico 3
(Date:7/1/2015)... 2015 Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... inflammatory disease and neurologic disorders, announced today the results ... citrate, the Company,s lead compound. Results from the study ... can significantly inhibit the activation of inflammatory proteins in ... this compound in a Phase 1 clinical trial under ...
(Date:7/1/2015)... , July 1, 2015  BioPharmX Corporation (NYSE MKT: ... underwritten public offering of 3,636,364 shares of its common ... per share. BioPharmX has granted the underwriters a 30-day ... common stock at the public offering price. ... an existing stockholder, has agreed to purchase 1,081,081 shares ...
(Date:6/30/2015)... Scotland , July 1, 2015 ... joins Nu C ana team   ... ProTide technology to develop and commercialise a portfolio of ... Chris McGuigan as Chief Scientific Officer. ... ProTide technology. He is currently Professor of Medicinal Chemistry ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 2BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 3Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3
... Amgen (Nasdaq: AMGN ), today announced the ... privately held biotechnology company based in Woburn, Mass., with ... a novel investigational oncolytic vaccine in Phase 3 clinical ... melanoma and head and neck cancer. The acquisition was ...
... , a leader in bioinformatics software and knowledge integration, ... license for Pathway Studio ® Enterprise system that ... MedScan® text processing technology for site-wide use. Pathway Studio ... pathways and develop mechanistic rationale for disease based on ...
Cached Medicine Technology:Amgen Completes Acquisition of BioVex 2Amgen Completes Acquisition of BioVex 3Amgen Completes Acquisition of BioVex 4Site-wide License for Ariadne's Pathway Studio Renewed by NCI 2
... OmniMD Medical Billing system allows a ... accounting. It is integrated with the ... The system interfaces with electronic clearinghouses ... With a set of reports, it ...
... CPNG3 single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... CPNG3 reagent provides a long shelf ...
... Infinity Uric Acid single liquid stable ... convenience of single liquid stability to ... error and provide quick result turnaround ... Infinity Uric Acid reagent provides a ...
... Oxidase single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... Oxidase reagent provides a long shelf ...
Medicine Products: